Revolve Surgical

Revolve Surgical makes a table-mounted, zero-footprint robotic platform for minimally invasive soft-tissue surgery. One person can set it up and run it, and it is built to take AI and data analytics later. It received FDA 510(k) clearance in early 2026. It is a Y Combinator graduate that has also been supported by Creative Destruction Lab and ventureLAB. Its only reported funding is a seed round in 2021, and the amount is not public. It plans to sell devices mainly to US healthcare providers, and Tracxn lists 8 employees as of mid-2026.